{
    "id": "8fcd9ba1-e742-4ed6-9fd0-3a790da34bf8",
    "indications": "Carefully consider the potential benefits and risks of nabumetone tablets and other treatment options before deciding to use nabumetone tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see \n                        WARNINGS\n                     ).\n\n                  Nabumetone tablets are indicated for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis.",
    "contraindications": "Carefully consider the potential benefits and risks of nabumetone tablets and other treatment options before deciding to use nabumetone tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see \n                        WARNINGS\n                     ).\n\n                  After observing the response to initial therapy with nabumetone tablets, the dose and frequency should be adjusted to suit an individual patient's needs.",
    "warningsAndPrecautions": "Nabumetone tablets USP, 500 mg are white, oval-shaped, film-coated, biconvex tablets debossed with “3670” on one side of the tablet and plain on the other side. They are available in bottles of 100 and 500.\n                  NDC 0591-3670-01...............................bottles of 100\nNDC 0591-3670-05...............................bottles of 500\n                  Nabumetone tablets USP, 750 mg are pink, oval-shaped, film-coated, biconvex tablets debossed with “3671” on one side of the tablet and plain on the other side. They are available in bottles of 100 and 500.\n                  NDC 0591-3671-01...............................bottles of 100\nNDC 0591-3671-05...............................bottles of 500\n                  Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. \n                  Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).\n                  Dispense with Medication Guide available at: www.tevausa.com/medguides\n                  Manufactured In India By:\n                     Watson Pharma Private Ltd.\n                     \nVerna, Salcette Goa 403 722 INDIA\n                  Manufactured For:\n                     Teva Pharmaceuticals\n                     Parsippany, NJ 07054\n                  Rev. F 10/2024",
    "adverseReactions": "Nabumetone tablets are contraindicated in patients with known hypersensitivity to nabumetone or product excipients.\n\n                  Nabumetone tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients (see \n                        WARNINGS\n                     \n                     ,\n                     \n                         Anaphylactoid Reactions\n                      and \n                        PRECAUTIONS\n                     \n                     ,\n                     \n                         General\n                     \n                     , \n                     Preexisting Asthma).\n\n                  • In the setting of coronary artery bypass graft (CABG) surgery [see \n                        Warnings\n                     ].",
    "ingredients": [
        {
            "name": "NABUMETONE",
            "code": "LW0TIW155Z"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        }
    ],
    "organization": "Actavis Pharma, Inc.",
    "name": "Nabumetone",
    "effectiveTime": "20241007"
}